From: The N-shaped orthotopic ileal neobladder: functional outcomes and complication rates in 119 patients
Number of patients (Male/Female) | 119 (102/17) |
Age (years) | Male: 59 (34–74) Female: 55 (29–68) |
Follow up (months) | 75 (3–204) |
Operative indication | |
Transitional cell carcinoma | 113 pts |
Interstitial cystitis | 2 pts |
Vesicorectal fistula | 1 pt |
Prostate cystadenoma | 1 pt |
Persistant leakage from continent vesicostomy | 1 pt |
Bladder wall calcification after BCG | 1 pt |
Operation time (min) | 210 (120–360) |
Blood loss (mL) | 1100 (100–3600) |
T stage | Preoperative | Postoperative | Positive LN |
---|---|---|---|
T0 | 3 (2.7 %) | 29 (25.7 %) | 1/29 (3.4 %) |
Tx | 3 (2.7 %) | 0 (0 %) | 0 (0 %) |
Tis | 5 (4.4 %) | 9 (7.9 %) | 0/9 (0 %) |
Ta | 1 (0.8 %) | 5 (4.4 %) | 0/5 (0 %) |
T1 | 22 (19.5 %) | 15 (13.3 %) | 1/15 (6.7 %) |
T2 | 75 (66.4 %) | 22 (19.5 %) | 4/22 (18.2 %) |
T3 | 4 (3.5 %) | 29 (25.7 %) | 12/29 (41.4 %) |
T4 | 0 (0 %) | 4 (3.5 %) | 3/4 (75 %) |
Total | 113 (100 %) | 113 (100 %) | 21/113 (18.6 %) |